VAERS reports by lot

GSK Hepatitis A lot 7YA99: VAERS reports

64 VAERS reports list lot 7YA99 as a GSK Hepatitis A vaccine, received between 2022-04-05 and 2024-03-18. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
64
Reports
0%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological431%
General / Systemic (non-local)323%
Injection-site / Local reaction323%
Gastrointestinal215%
Dermatological (non-injection-site)18%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Virginia7
Michigan4
Illinois3
Massachusetts3
North Carolina3
Florida3
California3
Colorado3
Tennessee2
New Jersey2
Arizona2
Ohio2

Reports by month received

MonthReportsBar
2022-041
2022-054
2022-061
2022-071
2022-081
2022-091
2022-1026
2022-1114
2022-124
2023-013
2023-024
2023-041
2023-061
2023-101
2024-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK Hepatitis A lots (A–Z): 77X47 · 7HJ74 · 7NX57 · 9255P · 92DJ3 · 95BJ9

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.